CADTH
  • Home
  • Contact Us
  • Advanced Search
  • Sitemap
  • Extranet
  • Help
  •  
  • Français
  • About
    CADTH
    • Corporate Profile
    • CADTH Products
    • Therapeutic Review
    • Contact Us
    • Terms of Use
  • Knowledge
    Exchange
    • Knowledge Transfer
    • Liaison Program
    • Partnerships and Strategic Initiatives
  • Health Technology
    Assessment
    • HTA News
    • HTA Reports and Publications
    • Programs
    • HTA Projects
    • HTA Events
    • Advisory Committees
    • FAQ
    • Suggest a Topic
    • Contact Us
  • Common Drug
    Review
    • CDR Overview
    • CDR Process
    • Advisory Committees
    • Recommendations and Status of Drug Submissions
    • Search CDR Drug Database
    • CDR Update
    • Filing a Submission
    • CDR Links
    • CDR News
    • Events
    • Contact Us
  • Canadian Optimal Medication
    Prescribing & Utilization Service
    • Search Our Publications and Tools
    • Insulin Analogue Therapy
    • Blood Glucose Test Strips
    • Second-line therapy for patients with diabetes
    • Rx for Change Database
    • Proton Pump Inhibitor Therapy
    • Optimal Therapy Resources
    • COMPUS Communiqué
    • About COMPUS
    • Advisory Committees
    • COMPUS Process
    • Contact Us
  • Policy
    Forum
    • Policy Options Documents
    • Policy Information Documents
    • Discussion Papers
    • HTIS reports commissioned by Policy Forum
    • Terms of Reference
    • Member Listing
    • Contacts
  • Media Centre
  • Events
  • Careers
  • Subscribe
  • Related Links
  • CADTH @ 20
This is the beginning of the side menu Internal link to skip the top and side navigation menus and go directly to the page content

Health Technology Assessment

  • HTA Reports and Publications
    • Search All HTA Publications
    • Technology Reports
    • Technology Overviews
    • Health Technology Update
    • Issues in Emerging Health Technologies
    • Emerging Drug List
    • Environmental Scans
  • Programs
  • HTA Projects
  • Advisory Committees
  • Suggest a Topic
  • HTA News
  • HTA Events
  • FAQ
  • Contact Us
  • Health Technology Assessment
  • » HTA Reports and Publications
  • » Search All HTA Publications

Search All HTA Publications



What is this?

Results 1 - 10 of 560

Next »Page

  1. Recombinant Activated Factor VII for Prevention of Bleeding Unrelated to Hemophilia: Clinical and Economic Systematic Review

    February 4, 2010

    CADTH’s health technology assessment report examines the clinical efficacy and cost-effectiveness of off-label use of recombinant activated factor VII (rFVIIa), an agent currently approved to control bleeding in patients with either hemophilia A or B and clotting factor inhibitors. &nb...

    View Summary

  2. H1N1 and Seasonal Influenza Vaccine Practices across Canadian Jurisdictions: Issue 6

    December 23, 2009

      Download this report Context Objective  Findings Knowledge Gaps Conclusion References Context The delivery of influenza vaccination programs in 2009 required rapid planning and implementation. Considerable uncertainty arose regarding the timing of H1N1 and seasonal ...

    View Summary

  3. Clopidogrel versus Other Antiplatelet Agents in the Secondary Prevention of Vascular Events in Adults with Cerebrovascular Disease: Clinical and Cost-Effectiveness Analyses

    December 22, 2009

    CADTH’s health technology assessment report on clopidogrel versus other antiplatelet agents examines the clinical efficacy and cost-effectiveness of this treatment strategy for secondary prevention of vascular events in adults with cerebrovascular disease. The report also assesses cur...

    View Summary

  4. Addendum to the Canadian Agency for Drugs and Technologies in Health Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products

    December 22, 2009

    This addendum to CADTH’s Guidelines for the Economic Evaluation of Health Technologies (3rd Edition) is intended to provide specific guidance on the methods used to conduct high-quality economic evaluations of oncology products. The oncology-specific guidelines should be considered a comp...

    View Summary

  5. Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada

    December 9, 2009

    An amendment to this report to reflect the inclusion of additional portable monitoring devices that are licensed in Canada has been made. The revised report is now available. View Report (38 pages) View Executive Summary (3 pages) Context and Policy Issues Obstructive sleep apnea...

    View Summary

  6. Health Technology Update Issue 12

    December 8, 2009

    Download the PDF version This issue of Health Technology Update features a new application of an old tool for diabetes screening and diagnosis. This issue also provides insight into activity-based funding and provincial interest in this payment model as a way to sustain health care budgets. Addi...

    View Summary

  7. Reassessment of Health Technologies: Obsolescence and Waste

    December 4, 2009

    CADTH’s report on the reassessment of health technologies is intended to inform and encourage further discussion about the appropriate use of existing health technologies. This report considers practical and policy issues related to health technology obsolescence and proposes a framework f...

    View Summary

  8. Implications of ISO Certification and Licensing of Patient Management Software: Issue 5

    November 25, 2009

    In This Issue

    • Context
    • Objective
    • Findings
    • Knowledge Gaps
    • Conclusion
    • References

  9. The Location of High-Intensity Focused Ultrasound Facilities in Canada for the Treatment of Prostate Cancer and Access to Treatment - Issue 4

    November 18, 2009

  10. Carbon Ion Radiation Therapy - Issue 3

    November 13, 2009

Next »Page

Top of Page Privacy Policy Feedback Terms of use

© 2010 Canadian Agency for Drugs and Technologies in Health

Last Updated February 8, 2010